Update on antimicrobial resistance inClostridium difficile

Gao Qiong,Huang Haihui
DOI: https://doi.org/10.16288/j.yczz.15-131
2015-01-01
Hereditas
Abstract:Clostridium difficile is the leading cause of healthcare-associated diarrhea. Since 2002, the morbidity and mortality rates ofC. difficile infection have increased dramatically in Europe and North America. The emergence ofC. difficile strains that are resistant to multiple antimicrobial agents can complicate prevention programs and po-tential treatment. Although most clinical isolates are still susceptible to metronidazole and vancomycin, heteroresis-tance to metronidazole and increasing vancomycin MICs (minimum inhibitory concentrations) have been reported. The prevalence of resistance to other antimicrobial agents, including erythromycin and moxifloxacin, is highly varia-ble in different countries and regions. The exact mechanism of reduced susceptibility to metronidazole or vancomycin is still not clear. The principal mechanism of erythromycin, fluoroquinolones and rifamycins resistance inC. difficile is determined by target alterations. This review will focus primarily on the antimicrobial susceptibility patterns and resistance mechanisms ofC. difficile in order to provide an up-to-date review on the topic.
What problem does this paper attempt to address?